WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients
NCT02182570 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2014-07-14
Summary
The safety and efficacy of WAL 801 CL (epinastine hydrochloride) Dry Syrup in the treatment of atopic dermatitis in children was evaluated and plasma drug concentrations were measured.
Conditions
- Dermatitis, Atopic
Interventions
- DRUG
-
WAL 801 CL dry syrup
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-06-30
- Primary Completion
- 2002-02-28
More Related Trials
-
A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin
NCT02120833 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
NCT01375205 ·Status: COMPLETED ·Phase: NA
-
Study Of Atopic Dermatitis In Pediatrics
NCT00257569 ·Status: COMPLETED ·Phase: PHASE3
-
This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)
NCT05608343 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and Children
NCT04740892 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)
NCT00932074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
NCT00465699 ·Status: UNKNOWN ·Phase: NA
-
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
NCT03257644 ·Status: COMPLETED ·Phase: PHASE1
-
Study of LW402 in Moderate-to-Severe Atopic Dermatitis
NCT07186387 ·Status: COMPLETED ·Phase: PHASE2
-
Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
NCT00125333 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin
NCT02857062 ·Status: COMPLETED ·Phase: NA
-
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
NCT07259343 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of DNK333 in Atopic Dermatitis Patients
NCT01033097 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
NCT06807268 ·Status: RECRUITING ·Phase: PHASE3
-
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
NCT06807281 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
NCT03627767 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
NCT04018027 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis
NCT07329101 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis
NCT04684485 ·Status: COMPLETED ·Phase: PHASE2
-
A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
NCT05571943 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
NCT03849716 ·Status: ACTIVE_NOT_RECRUITING
-
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
NCT00806221 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis
NCT04504279 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT06880276 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
NCT01174511 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2